The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Copyright 2025 NPR
© 2025 Ideastream Public Media
1375 Euclid Avenue, Cleveland, Ohio 44115
(216) 916-6100 | (877) 399-3307
WKSU is a public media service licensed to Kent State University and operated by Ideastream Public Media.
1375 Euclid Avenue, Cleveland, Ohio 44115
(216) 916-6100 | (877) 399-3307
WKSU is a public media service licensed to Kent State University and operated by Ideastream Public Media.
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations